MedPath

Digoxin

Generic Name
Digoxin
Brand Names
Digox, Lanoxin
Drug Type
Small Molecule
Chemical Formula
C41H64O14
CAS Number
20830-75-5
Unique Ingredient Identifier
73K4184T59

Overview

Digoxin is one of the oldest cardiovascular medications used today. It is a common agent used to manage atrial fibrillation and the symptoms of heart failure. Digoxin is classified as a cardiac glycoside and was initially approved by the FDA in 1954. This drug originates from the foxglove plant, also known as the Digitalis plant, studied by William Withering, an English physician and botanist in the 1780s. Prior to this, a Welsh family, historically referred to as the Physicians of Myddvai, formulated drugs from this plant. They were one of the first to prescribe cardiac glycosides, according to ancient literature dating as early as the 1250s.

Background

Digoxin is one of the oldest cardiovascular medications used today. It is a common agent used to manage atrial fibrillation and the symptoms of heart failure. Digoxin is classified as a cardiac glycoside and was initially approved by the FDA in 1954. This drug originates from the foxglove plant, also known as the Digitalis plant, studied by William Withering, an English physician and botanist in the 1780s. Prior to this, a Welsh family, historically referred to as the Physicians of Myddvai, formulated drugs from this plant. They were one of the first to prescribe cardiac glycosides, according to ancient literature dating as early as the 1250s.

Indication

Digoxin is indicated in the following conditions: 1) For the treatment of mild to moderate heart failure in adult patients. 2) To increase myocardial contraction in children diagnosed with heart failure. 3) To maintain control ventricular rate in adult patients diagnosed with chronic atrial fibrillation. In adults with heart failure, when it is clinically possible, digoxin should be administered in conjunction with a diuretic and an angiotensin-converting enzyme (ACE) inhibitor for optimum effects.

Associated Conditions

  • Myocardial contractility
  • Ventricular Arrhythmia
  • Mild to moderate heart failure

FDA Approved Products

Digoxin
Manufacturer:A-S Medication Solutions
Route:ORAL
Strength:125 ug in 1 1
Approved: 2019/05/15
NDC:50090-5276
Digoxin
Manufacturer:Northwind Pharmaceuticals, LLC
Route:ORAL
Strength:0.125 mg in 1 1
Approved: 2023/04/13
NDC:51655-403
Digoxin
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:0.25 mg in 1 1
Approved: 2021/07/21
NDC:59651-438
Digoxin
Manufacturer:Amneal Pharmaceuticals of New York LLC
Route:ORAL
Strength:125 ug in 1 1
Approved: 2019/06/01
NDC:0115-9811
Digoxin
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:250 ug in 1 1
Approved: 2011/12/28
NDC:54868-0055

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath